scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Gino Seravalle | Q56988550 |
Guido Grassi | Q61303944 | ||
P2093 | author name string | Fosca Quarti-Trevano | |
P2860 | cites work | Pathogenesis of hypertension | Q34274333 |
Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives | Q35045333 | ||
The activity of single vasoconstrictor nerve units in hypertension | Q35074424 | ||
A sympathetic view of the sympathetic nervous system and human blood pressure regulation | Q36208762 | ||
Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. | Q37024579 | ||
Renal medullary oxidative stress, pressure-natriuresis, and hypertension | Q37137810 | ||
Is neurogenic hypertension related to vascular inflammation of the brainstem? | Q37202058 | ||
Do changes in the coupling between respiratory and sympathetic activities contribute to neurogenic hypertension? | Q37469135 | ||
Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia | Q37554990 | ||
Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension | Q37587173 | ||
Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives | Q37590008 | ||
Integration of reflex responses in the control of blood pressure and vascular resistance | Q39811170 | ||
Plasma catecholamines and essential hypertension. An analytical review | Q40144106 | ||
Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. | Q40516349 | ||
Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure | Q41844127 | ||
Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat. | Q42931820 | ||
Renal sympathetic-nerve ablation for uncontrolled hypertension | Q43285253 | ||
Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat | Q44311655 | ||
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy | Q44504046 | ||
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation | Q44650536 | ||
Sympathetic-mediated hypertension of awake juvenile rats submitted to chronic intermittent hypoxia is not linked to baroreflex dysfunction. | Q45939574 | ||
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives | Q46084499 | ||
Relationship between central sympathetic activity and stages of human hypertension | Q48010908 | ||
A spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitation | Q48460893 | ||
Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. | Q51750627 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arterial hypertension | Q41861 |
P304 | page(s) | 581-586 | |
P577 | publication date | 2009-12-11 | |
P1433 | published in | Experimental Physiology | Q1091760 |
P1476 | title | The 'neuroadrenergic hypothesis' in hypertension: current evidence | |
P478 | volume | 95 |
Q92512579 | Acute salt loading induces sympathetic nervous system overdrive in mice lacking salt-inducible kinase 1 (SIK1) |
Q38151943 | Adipose afferent reflex: sympathetic activation and obesity hypertension. |
Q48679737 | Age related diastolic function in amateur athletes |
Q48310428 | Angiotensin AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats |
Q42292543 | Angiotensin II acting on brain AT1 receptors induces adrenaline secretion and pressor responses in the rat. |
Q34534106 | Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats |
Q35815199 | Angiotensin II status and sympathetic activation among hypertensive patients in Uganda: a cross-sectional study |
Q34472153 | Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats |
Q38245885 | Arterial innervation in development and disease |
Q45873654 | Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats |
Q38196354 | Autonomic nervous system dysregulation in pediatric hypertension. |
Q22306336 | Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension |
Q36244806 | Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease |
Q50991341 | Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat. |
Q85723642 | Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat |
Q62828925 | Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms |
Q44332515 | Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat. |
Q47865079 | Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats |
Q36456727 | Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals |
Q48139257 | Differential gene expression of three nitric oxide synthases is consistent with increased nitric oxide in the hindbrain of broilers with cold-induced pulmonary hypertension |
Q37954116 | Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism |
Q87267219 | Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension |
Q47917498 | Early life stress and post-weaning high fat diet alter tyrosine hydroxylase regulation and AT1 receptor expression in the adrenal gland in a sex dependent manner. |
Q42159015 | Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453). |
Q35341894 | Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure |
Q48233757 | Endogenous hydrogen peroxide in paraventricular nucleus mediates sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats |
Q38156714 | Evidence for the role of isometric exercise training in reducing blood pressure: potential mechanisms and future directions. |
Q30354373 | Ganglionic GFAP + glial Gq-GPCR signaling enhances heart functions in vivo |
Q33889435 | Genes influencing circadian differences in blood pressure in hypertensive mice |
Q54378215 | Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. |
Q48394438 | Impressive blood pressure and heart rate response after percutaneous renal denervation in a woman with morbid obesity and severe drug-resistant hypertension |
Q36836484 | Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease |
Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
Q50620942 | Left ventricular twisting modifications in patients with left ventricular concentric hypertrophy at increasing after-load conditions. |
Q38267484 | Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences |
Q44523641 | Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure |
Q37943377 | Nebivolol for the treatment of heart failure |
Q89425257 | Neurogenic hypertension: pathophysiology, diagnosis and management |
Q38013692 | Neurogenic hypertension: revelations from genome-wide gene expression profiling |
Q36824063 | Neuroimmune communication in hypertension and obesity: a new therapeutic angle? |
Q33939221 | No elevated plasma catecholamine levels during sleep in newly diagnosed, untreated hypertensives |
Q48194227 | Oxidant and enzymatic antioxidant status (gene expression and activity) in the brain of chickens with cold-induced pulmonary hypertension. |
Q41943162 | Oxidative stress in the brain causes hypertension via sympathoexcitation |
Q37846532 | Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension |
Q37892042 | Paracrine control of vascular innervation in health and disease |
Q26825107 | Potential clinical application of recently discovered brain mechanisms involved in hypertension |
Q60162187 | Quantifying sympathetic neuro-haemodynamic transduction at rest in humans: insights into sex, ageing and blood pressure control |
Q47160543 | Quantity and Quality of Carbohydrate Intake during Pregnancy, Newborn Body Fatness and Cardiac Autonomic Control: Conferred Cardiovascular Risk? |
Q38122303 | Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension |
Q48983840 | Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats |
Q42476216 | Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat. |
Q46514659 | SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats |
Q29999437 | Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects |
Q93346207 | Sex-specific long-term blood pressure regulation: Modeling and analysis |
Q47396920 | Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats |
Q48234848 | Sleep disturbance among spontaneously hypertensive rats is mediated by an α1-adrenergic mechanism |
Q36303921 | Stress-dependent hypertension and the role of T lymphocytes |
Q37859637 | Sympathetic mechanisms, organ damage, and antihypertensive treatment |
Q64938618 | Systemic angiotensin II does not increase cardiac sympathetic nerve activity in normal conscious sheep |
Q44050848 | The benefits of endurance training in cardiomyocyte function in hypertensive rats are reversed within four weeks of detraining |
Q28118905 | The crystal structure of human dopamine β-hydroxylase at 2.9 Å resolution |
Q87473936 | The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications |
Q33805761 | Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension |
Q57791612 | Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters |
Q42749550 | c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats |
Search more.